Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2024 third quarter earnings
what-you-need-to-know-about-johnson-johnsons-2024-third-quarter-earnings-1024.png

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

This morning, Johnson & Johnson shared its 2024 third quarter earnings report.

Since its founding in 1886 the company has been committed to innovation—today, more than 130,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.

“Johnson & Johnson’s performance in the third quarter reflects the diversification of our business and forward-looking, disciplined approach as we continue to invest in breakthrough innovation and acquisitions such as V-Wave that further bolster and differentiate our pipeline,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “As we wind down 2024, we are focused on advancing our pipeline further, positioning the business for continued growth in 2025 and beyond.”

For more details about the company’s 2024 third quarter results and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.

2024-third-quarter-earnings-infographic-1024.png

Johnson & Johnson’s 2024 third quarter earnings

Read the earnings press release, which includes full financial data for the third quarter of 2024.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

What are clinical trials?

Behind every innovative medicine, treatment and therapy is a clinical trial. To help you understand them better, here’s a closer look at how they work.

Meet two Johnson & Johnson nurse educators dedicated to teaching cancer care providers

Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 50 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.